Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pirotinib is an orally available inhibitor targeting the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, exhibiting potential antineoplastic activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Pirotinib is an orally available inhibitor targeting the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, exhibiting potential antineoplastic activity. |
Alias | M8R6ETA52F, Kbp-5209 |
Molecular Weight | 510 |
Formula | C27H29ClFN5O2 |
Cas No. | 1363358-86-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.